Description
PONATINIB (ICLUSIG) 45MG TAB, 30/BT
First action · last action
2014-11-25 · 2015-03-11
Transactions
2
First transaction's obligation
$21,813
Base + all options value (sum of deltas)
$21,651
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D3005E
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-11-25+$21,813= $21,813
- Mod P000012015-03-11-$162= $21,651
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-11-25 | +$21,813 | $21,813 | PONATINIB (ICLUSIG) 45MG TAB, 30/BT |
| Mod P00001· FUNDING ONLY ACTION | 2015-03-11 | −$162 | $21,651 | PONATINIB (ICLUSIG) 45MG TAB, 30/BT |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI EVMMLCKBZS47)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25219F0494 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $11,502 | FY2019 |
| 36C24919N0606 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $23,004 | FY2019 |
| 36C25219F0450 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $11,502 | FY2019 |
| 36C24919F0373 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $11,502 | FY2019 |
| 36C24519F0682 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $0 | FY2019 |
| 36C25219F0412 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $11,502 | FY2019 |
Other recipients under 6505 from 506-ANN ARBOR (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25116F1245 | CEPHEID | 506-ANN ARBOR | $87,847 | FY2016 |
| VA25116P1231 | MCKESSON CORPORATION | 506-ANN ARBOR | $27,127 | FY2016 |
| VA25116P1184 | MCKESSON CORPORATION | 506-ANN ARBOR | $9,200 | FY2016 |
| VA25116F1111 | CSL BEHRING L.L.C. | 506-ANN ARBOR | $26,724 | FY2016 |
| VA25116F0914 | BAYER HEALTHCARE PHARMACEUTICALS INC | 506-ANN ARBOR | $148,746 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25115F0445_3600_V797D3005E_3600 · retrieved 2026-09-26.